These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8088324)

  • 1. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins.
    Baker D; Butler D; Scallon BJ; O'Neill JK; Turk JL; Feldmann M
    Eur J Immunol; 1994 Sep; 24(9):2040-8. PubMed ID: 8088324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
    Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
    Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
    Selmaj K; Raine CS; Cross AH
    Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression.
    Glabinski AR; Bielecki B; Kawczak JA; Tuohy VK; Selmaj K; Ransohoff RM
    Autoimmunity; 2004; 37(6-7):465-71. PubMed ID: 15621573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody.
    Haak-Frendscho M; Marsters SA; Mordenti J; Brady S; Gillett NA; Chen SA; Ashkenazi A
    J Immunol; 1994 Feb; 152(3):1347-53. PubMed ID: 8301136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.
    Weinberg AD; Wegmann KW; Funatake C; Whitham RH
    J Immunol; 1999 Feb; 162(3):1818-26. PubMed ID: 9973447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis.
    Plessner HL; Lin PL; Kohno T; Louie JS; Kirschner D; Chan J; Flynn JL
    J Infect Dis; 2007 Jun; 195(11):1643-50. PubMed ID: 17471434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4.
    Williams RO; Ghrayeb J; Feldmann M; Maini RN
    Immunology; 1995 Mar; 84(3):433-9. PubMed ID: 7751027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization.
    Shi X; Semkova I; Müther PS; Dell S; Kociok N; Joussen AM
    Exp Eye Res; 2006 Dec; 83(6):1325-34. PubMed ID: 16959248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
    J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo.
    Siegel SA; Shealy DJ; Nakada MT; Le J; Woulfe DS; Probert L; Kollias G; Ghrayeb J; Vilcek J; Daddona PE
    Cytokine; 1995 Jan; 7(1):15-25. PubMed ID: 7538333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10.
    Crisi GM; Santambrogio L; Hochwald GM; Smith SR; Carlino JA; Thorbecke GJ
    Eur J Immunol; 1995 Nov; 25(11):3035-40. PubMed ID: 7489740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.
    Mackay F; Majeau GR; Lawton P; Hochman PS; Browning JL
    Eur J Immunol; 1997 Aug; 27(8):2033-42. PubMed ID: 9295042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
    Lavasani S; Dzhambazov B; Andersson M
    Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.